Business Context and Reporting Period
This Form 8-K Current Report was filed by vTv Therapeutics Inc. on December 19, 2025. The filing reports a corporate governance amendment approved by the Board of Directors on the same date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a by-law amendment and does not contain financial statements or operational metrics.
Material Changes
The material change reported is an amendment to the Company's Second Amended and Restated By-Laws:
- Section 2.8 of Article II was amended to reduce the quorum requirement for any meeting of stockholders to 33.4%.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the procedural update regarding the quorum requirement.
Key Facts for Investor Verification
- Verify the effective date of the quorum reduction to 33.4% for future stockholder meetings.
- Review the attached Exhibit 3.1 (First Amendment to the Second Amended and Restated By-Laws) for full legal text.
- Confirm that no other financial or operational events were reported in this specific filing.